SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-344532"
 

Search: onr:"swepub:oai:DiVA.org:uu-344532" > Current Progress To...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Ehrhardt, CarstenTrinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland. (author)

Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs : Summary Proceedings of the First Workshop on Drug Transporters in the Lungs

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • Elsevier BV,2017
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-344532
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-344532URI
  • https://doi.org/10.1016/j.xphs.2017.04.011DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin hosted the "1st Workshop on Drug Transporters in the Lungs" in September 2016 to discuss the impact of transporters on pulmonary drug disposition and their roles as drug targets in lung disease. The workshop brought together about 30 scientists from academia and pharmaceutical industry from Europe and Japan and addressed the primary questions: What do we know today, and what do we need to know tomorrow about transporters in the lung? The 3 themes of the workshop were: (1) techniques to study drug transporter expression and actions in the lungs; (2) drug transporter effects on pulmonary pharmacokinetics-case studies; and (3) transporters as drug targets in lung disease. Some of the conclusions of the workshop were: suitable experimental models that allow studies of transporter effects are available; data from these models convincingly show a contribution of both uptake and efflux transporters on pulmonary drug disposition; the effects of transporters on drug lung PK is now better conceptualized; some transporters are associated with lung diseases. However, more work is needed to establish which of the available models best translate to the clinical situation.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Backman, PerMylan Global Resp Grp, Sandwich, Kent, England. (author)
  • Couet, WilliamUniv Poitiers, CHU Poitiers, UFR Med Pharm, Inserm,U1070, Poitiers, France. (author)
  • Edwards, ChrisGlaxoSmithKline Medicines Res Ctr, Refractory Resp Inflammat DPU, Stevenage, Herts, England. (author)
  • Forbes, BenKings Coll London, Inst Pharmaceut Sci, London, England. (author)
  • Fridén, MarkusUppsala universitet,Institutionen för farmaceutisk biovetenskap,AstraZeneca R&D Gothenburg, Resp Inflammat & Autoimmun Innovat Med, Molndal, Sweden.,Translationell PKPD(Swepub:uu)mafri535 (author)
  • Gumbleton, MarkCardiff Univ, Sch Pharm & Pharmaceut Sci, Expt Therapeut, Cardiff, S Glam, Wales. (author)
  • Hosoya, Ken-IchiToyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut, Toyama, Japan. (author)
  • Kato, YukioKanazawa Univ, Fac Pharmaceut Sci, Dept Mol Pharmacotherapeut, Kanazawa, Ishikawa, Japan. (author)
  • Nakanishi, TakeoKanazawa Univ, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa, Japan. (author)
  • Takano, MikihisaHiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan. (author)
  • Terasaki, TetsuyaTohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan. (author)
  • Yumoto, RyokoHiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan. (author)
  • Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland.Mylan Global Resp Grp, Sandwich, Kent, England. (creator_code:org_t)

Related titles

  • In:Journal of Pharmaceutical Sciences: Elsevier BV106:9, s. 2234-22440022-35491520-6017

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view